Back to Journals » OncoTargets and Therapy » Volume 6

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Total article views   HTML views PDF downloads Totals
10,720 Dovepress* 9,623+ 1,437 11,060
PubMed Central* 1,097 396 1,493
Totals 10,720 1,833 12,553
*Since 29 November 2013
+Since July 2016

View citations on PubMed Central and Google Scholar